公开(公告)号：US20240307225A1

公开(公告)日：2024-09-19

申请号：US18585332

申请日：2024-02-23

Applicant: Alcon Inc.

Inventor： Andrew T. SCHIEBER ,  Charles L. EUTENEUER ,  David T. VAN METER ,  Kenneth M. GALT

IPC: A61F9/007 ,  A61B3/16 ,  A61M5/00 ,  A61M25/00

CPC classification number: A61F9/00781 ,  A61B3/16 ,  A61M5/00 ,  A61M25/00

Abstract: An illustrative method for reducing intraocular pressure in a patient may comprise deploying an ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye and administering a therapeutic agent comprising a Rho kinase (ROCK) inhibitor to the patient. The ocular implant may be configured to lower the intraocular pressure from an initial to a second pressure within a first range and the therapeutic agent may lower an intraocular pressure to a third pressure within a second range, the third pressure lower than the second pressure.